Key result
P-wave signal averaging parameters, including total P-wave duration ≥150 ms, did not significantly predict atrial fibrillation recurrences after electrical cardioversion (47% vs 31%; P=0.07).
Why the study?
Does P-wave signal averaging predict atrial fibrillation recurrences in patients after successful electrical cardioversion for persistent AF?
Cohort (n=133)
Does P-wave signal averaging predict atrial fibrillation recurrences in patients after successful electrical cardioversion for persistent AF?
Absolute Event Rate: 47% vs 31%
p-value: p=0.07
P-wave signal averaging immediately after electrical cardioversion does not predict atrial fibrillation recurrences in unselected patients with persistent AF.
P-wave signal averaging does not predict AF recurrence after cardioversion; leaves open its role in refined risk stratification.
BACKGROUND: Accurate markers of atrial fibrillation (AF) recurrences after electrical cardioversion (ECV) are lacking. This study was conducted to assess the value of P-wave signal averaging (SAPW) for predicting AF recurrences in a nonselected patients population submitted to ECV. METHODS: A total of 133 patients (107 males, 26 females, mean age 66 ± 9 years) were included after successful ECV for persistent AF (mean duration of AF 3.6 ± 2.2 months). The mean ejection fraction (EF) was 60 ± 9%, and left atrial (LA) diameter was 44 ± 6 mm. SAPW ECG was obtained immediately after ECV and patients were prospectively followed. RESULTS: During a mean follow-up of 8.9 ± 5.2 months, AF recurrences occurred in 40.6% (54/133). No SAPW parameters was statistically different between the group of patients with and the group without recurrences. Recurrences were less often observed in patients with a total P-wave duration <150 ms (16/52 or 31% vs 38/81 or 47% in patients with total P-wave duration ≥150 ms) but the difference was not statistically different (P = 0.07). P-wave duration was correlated with age (r = 0.32; P < 0.001) and left atrial diameter (r = 0.19; P = 0.02). Age, sex, structural heart disease, amiodarone therapy, or hypertension were not associated with AF recurrences but patients without recurrences had a shorter AF duration (P = 0.001) and more often had a history of previous ablation (P = 0.027). CONCLUSION: In this unselected "real-life" group of patients submitted to ECV for persistent AF, none of the SAPW parameters, including total filtered P-wave duration, was able to predict AF recurrences.
No takes yet. Share an insight, caveat, or question.
Blanche et al. (2014) conducted a cohort in Persistent atrial fibrillation (n=133). Total P-wave duration ≥150 ms on signal-averaged ECG vs. Total P-wave duration <150 ms was evaluated on Atrial fibrillation recurrences (p=0.07). P-wave signal averaging parameters, including total P-wave duration ≥150 ms, did not significantly predict atrial fibrillation recurrences after electrical cardioversion (47% vs 31%; P=0.07).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: